RAS signalling in energy metabolism and rare human diseases
- PMID: 29750912
- DOI: 10.1016/j.bbabio.2018.05.003
RAS signalling in energy metabolism and rare human diseases
Abstract
The RAS pathway is a highly conserved cascade of protein-protein interactions and phosphorylation that is at the heart of signalling networks that govern proliferation, differentiation and cell survival. Recent findings indicate that the RAS pathway plays a role in the regulation of energy metabolism via the control of mitochondrial form and function but little is known on the participation of this effect in RAS-related rare human genetic diseases. Germline mutations that hyperactivate the RAS pathway have been discovered and linked to human developmental disorders that are known as RASopathies. Individuals with RASopathies, which are estimated to affect approximately 1/1000 human birth, share many overlapping characteristics, including cardiac malformations, short stature, neurocognitive impairment, craniofacial dysmorphy, cutaneous, musculoskeletal, and ocular abnormalities, hypotonia and a predisposition to developing cancer. Since the identification of the first RASopathy, type 1 neurofibromatosis (NF1), which is caused by the inactivation of neurofibromin 1, several other syndromes have been associated with mutations in the core components of the RAS-MAPK pathway. These syndromes include Noonan syndrome (NS), Noonan syndrome with multiple lentigines (NSML), which was formerly called LEOPARD syndrome, Costello syndrome (CS), cardio-facio-cutaneous syndrome (CFC), Legius syndrome (LS) and capillary malformation-arteriovenous malformation syndrome (CM-AVM). Here, we review current knowledge about the bioenergetics of the RASopathies and discuss the molecular control of energy homeostasis and mitochondrial physiology by the RAS pathway.
Keywords: Bioenergetics; Development; Mitochondria; RAS; RASopathies.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Modeling RASopathies with Genetically Modified Mouse Models.Methods Mol Biol. 2017;1487:379-408. doi: 10.1007/978-1-4939-6424-6_28. Methods Mol Biol. 2017. PMID: 27924582 Review.
-
A review of craniofacial and dental findings of the RASopathies.Orthod Craniofac Res. 2017 Jun;20 Suppl 1(Suppl 1):32-38. doi: 10.1111/ocr.12144. Orthod Craniofac Res. 2017. PMID: 28643916 Free PMC article. Review.
-
[New insight of craniofacial and oral findings of the RASopathies].Zhonghua Kou Qiang Yi Xue Za Zhi. 2018 Dec 9;53(12):858-861. doi: 10.3760/cma.j.issn.1002-0098.2018.12.014. Zhonghua Kou Qiang Yi Xue Za Zhi. 2018. PMID: 30522213 Review. Chinese.
-
Pathogenesis of Growth Failure in Rasopathies.Pediatr Endocrinol Rev. 2019 May;16(Suppl 2):447-458. doi: 10.17458/per.vol16.2019.ad.pathogenesisrasopathies. Pediatr Endocrinol Rev. 2019. PMID: 31115196
-
The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of selected syndromes.Dev Period Med. 2014 Jul-Sep;18(3):285-96. Dev Period Med. 2014. PMID: 25182392 Review.
Cited by
-
Non-Mammalian Models for Understanding Neurological Defects in RASopathies.Biomedicines. 2024 Apr 10;12(4):841. doi: 10.3390/biomedicines12040841. Biomedicines. 2024. PMID: 38672195 Free PMC article. Review.
-
NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.Mol Metab. 2024 Feb;80:101876. doi: 10.1016/j.molmet.2024.101876. Epub 2024 Jan 10. Mol Metab. 2024. PMID: 38216123 Free PMC article.
-
KDM5-mediated activation of genes required for mitochondrial biology is necessary for viability in Drosophila.Development. 2023 Nov 1;150(21):dev202024. doi: 10.1242/dev.202024. Epub 2023 Nov 6. Development. 2023. PMID: 37800333 Free PMC article.
-
Lipid profile in Noonan syndrome and related disorders: trend by age, sex and genotype.Front Endocrinol (Lausanne). 2023 Jul 31;14:1209339. doi: 10.3389/fendo.2023.1209339. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37588986 Free PMC article.
-
Changes of RAS Pathway Phosphorylation in Lymphoblastoid Cell Lines from Noonan Syndrome Patients Carrying Hypomorphic Variants in Two NS Genes.Int J Mol Sci. 2023 Feb 17;24(4):4035. doi: 10.3390/ijms24044035. Int J Mol Sci. 2023. PMID: 36835447 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous